A. Melander

Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels

A. Melander, Pietro Folino-Gallo, T Walley et al. · Diabetologia · 2006 · 280 citations · Full text

Diabetes Management, Drug Discovery, Chronic Kidney Disease +11

Associations between smoking and β‐cell function in a non‐hypertensive and non‐diabetic populationSkaraborg Hypertension and Diabetes Project

Carl Johan Östgren, Ulf Lindblad, Jonas Ranstam et al. · Diabetic Medicine · 2000 · 80 citations

Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.

Dorte Worm, Jan Erik Henriksen, Allan Vaag et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 62 citations

Antilipolytic Drug Acipimox, Pharmacotherapy, Obesity +17

Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function

A. J�nsson, Tony Rydberg, A. Melander et al. · European Journal of Clinical Pharmacology · 1998 · 61 citations

Renal Function, Medicine, Diabetes +8

Glucose tolerance and mortality, including a substudy of tolbutamide treatment

William C. Knowler, G. Sartor, A. Melander et al. · Diabetologia · 1997 · 58 citations · Full text

Obesity, Metabolic Syndrome, Glucose Tolerance +7